Funakoshi-Tago M - Search Results

1

Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activation.

Tago K, Funakoshi-Tago M, Ohta S, Kawata H, Saitoh H, Horie H, Aoki-Ohmura C, Yamauchi J, Tanaka A, Matsugi J, Yanagisawa K. Tago K, et al. Mol Oncol. 2019 Nov;13(11):2493-2510. doi: 10.1002/1878-0261.12580. Epub 2019 Oct 18. Mol Oncol. 2019. PMID: 31580526 Free PMC article.

2

TRAF6 and C-SRC induce synergistic AP-1 activation via PI3-kinase-AKT-JNK pathway.

Funakoshi-Tago M, Tago K, Sonoda Y, Tominaga S, Kasahara T. Funakoshi-Tago M, et al. Eur J Biochem. 2003 Mar;270(6):1257-68. doi: 10.1046/j.1432-1033.2003.03487.x. Eur J Biochem. 2003. PMID: 12631284 Free article.

3

Tumor necrosis factor-induced nuclear factor kappaB activation is impaired in focal adhesion kinase-deficient fibroblasts.

Funakoshi-Tago M, Sonoda Y, Tanaka S, Hashimoto K, Tago K, Tominaga S, Kasahara T. Funakoshi-Tago M, et al. J Biol Chem. 2003 Aug 1;278(31):29359-65. doi: 10.1074/jbc.M213115200. Epub 2003 May 14. J Biol Chem. 2003. PMID: 12748169 Free article.

4

Functional role of c-Src in IL-1-induced NF-kappa B activation: c-Src is a component of the IKK complex.

Funakoshi-Tago M, Tago K, Andoh K, Sonoda Y, Tominaga S, Kasahara T. Funakoshi-Tago M, et al. J Biochem. 2005 Feb;137(2):189-97. doi: 10.1093/jb/mvi018. J Biochem. 2005. PMID: 15749833

5

TRAF6 is a critical signal transducer in IL-33 signaling pathway.

Funakoshi-Tago M, Tago K, Hayakawa M, Tominaga S, Ohshio T, Sonoda Y, Kasahara T. Funakoshi-Tago M, et al. Cell Signal. 2008 Sep;20(9):1679-86. doi: 10.1016/j.cellsig.2008.05.013. Epub 2008 Jul 7. Cell Signal. 2008. PMID: 18603409

6

Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB.

Funakoshi-Tago M, Shimizu T, Tago K, Nakamura M, Itoh H, Sonoda Y, Kasahara T. Funakoshi-Tago M, et al. Biochem Pharmacol. 2008 Sep 1;76(5):662-71. doi: 10.1016/j.bcp.2008.06.015. Epub 2008 Jul 3. Biochem Pharmacol. 2008. PMID: 18644347

7

Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway.

Funakoshi-Tago M, Tago K, Kasahara T, Parganas E, Ihle JN. Funakoshi-Tago M, et al. Cell Signal. 2008 Nov;20(11):1995-2001. doi: 10.1016/j.cellsig.2008.07.008. Epub 2008 Jul 17. Cell Signal. 2008. PMID: 18682290

8

Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation.

Funakoshi-Tago M, Tago K, Nishizawa C, Takahashi K, Mashino T, Iwata S, Inoue H, Sonoda Y, Kasahara T. Funakoshi-Tago M, et al. Biochem Pharmacol. 2008 Dec 15;76(12):1681-93. doi: 10.1016/j.bcp.2008.09.012. Epub 2008 Sep 19. Biochem Pharmacol. 2008. PMID: 18848530

9

TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.

Funakoshi-Tago M, Kamada N, Shimizu T, Hashiguchi Y, Tago K, Sonoda Y, Kasahara T. Funakoshi-Tago M, et al. Cytokine. 2009 Feb;45(2):72-9. doi: 10.1016/j.cyto.2008.10.010. Epub 2008 Dec 16. Cytokine. 2009. PMID: 19091594

10

Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-kappaB p65 phosphorylation at serine 276.

Furusawa J, Funakoshi-Tago M, Tago K, Mashino T, Inoue H, Sonoda Y, Kasahara T. Furusawa J, et al. Cell Signal. 2009 May;21(5):778-85. doi: 10.1016/j.cellsig.2009.01.021. Epub 2009 Jan 9. Cell Signal. 2009. PMID: 19168128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters